TRUE: Menthol unrelated to cigarette health risks

Don’t let politics cloud the scientific facts

By William R. True

 The Washington Times

 5:33 p.m., Monday, October 4, 2010

 Americans increasingly look to the Food and Drug Administration (FDA) to guide them in their everyday decisions regarding the foods they eat and the drugs they take. Recently, FDA Commissioner Margaret A. Hamburg reminded a drug advisory committee to “follow the science wherever it leads and the rest will fall into place.” It was a telling reminder that a science-based fact foundation is essential to the FDA’s decisions and, consequently, its mission and credibility.

FDA Guidelines for Determining Eligibility for Advisory Committees are Ridiculous and Ensure that Conflicts of Interest Will Continue to Plague Agency

Yesterday, I called for the removal of four FDA Tobacco Products Scientific Advisory Committee (TPSAC) panel members – Dr. Neal Benowitz, Dr. Jack Henningfield, Dr. Dorothy Hatsukami, and Dr. Jonathan Samet – because they have significant conflicts of interest with pharmaceutical companies that make it impossible for them to offer objective advice to the Agency on federal tobacco regulatory policy.

A major issue that the panel will soon consider is regulation of dissolvable tobacco products. These are a direct threat to the profits of pharmaceutical companies because they may be used as an alternative for smoking cessation. The threat is so significant that GlaxoSmithKline petitioned the FDA to remove these products from the market.

Morgan Stanley Report on TPSAC

MORGAN STANLEY RESEARCH

Read the complete report

TOBACCO: FDA MENTHOL REPORT UPDATE: STILL WAITING FOR BALANCE… – September 27, 2010 GMT (7 pgs/ 64 kb)

David Adelman  +1 (1)212 761 6382  Morgan Stanley & Co. Incorporated Matthew Grainger  (212) 761 8023 Toby McCullagh  +44 (0)20 7425 6636  Morgan Stanley & Co. International plc

Investment conclusion: The most interesting development from today’s initial meeting of the TPSAC Menthol Report Subcommittee was that the three tobacco industry representatives – at least at this point – will be excluded from the process of writing the recommendation. The FDA made this determination based on its view that manufacturers would not want to provide a competitor with proprietary information. However, we believe that Lorillard, for example, would waive any issues to allow its Chief Scientist to remain fully engaged in the subcommittee’s menthol evaluation process.

GlaxoSmithKline Urges FDA to Withdraw Dissolvable Tobacco

 

 GlaxoSmithKline said Monday that it urged the Food and Drug Administration to take oral dissolvable tobacco products off the market “until their sponsors can demonstrate to FDA that their marketing is appropriate for the protection of public health.” The move shows how battle lines are emerging between pharmaceutical companies and tobacco companies in the bid to attract sales from cigarette smokers who are considering alternatives to their daily habit.  http://online.wsj.com/article/SB10001424052748703694204575518294130892622.html
 
 

RCMP Seize Contraband Tobacco

LONDON, ON, Sept. 22 /CNW/ – As the result of an investigation involving the London Customs & Excise Section of the Royal Canadian Mounted Police with the assistance of London Police Service and the Eastern Region OPP Highway Patrol, three Search Warrants were executed on two vehicles and a storage unit located in London, Ontario. Officers seized approximately 5,200 contraband cigarettes. The brand names include Canadian Light, Canadian Menthol, Canadian Original and Putter’s Light. Also seized were Titan Phillies Cigars, Borkum Riff Pipe Tobacco and Backwoods Honey Berry Tobacco.   

This investigation is continuing and no charges have been laid to date.